Jasmine Sethi (@jasminenephro) 's Twitter Profile
Jasmine Sethi

@jasminenephro

Assistant Professor Nephrology @PGIMER Chandigarh Passion ☀️Onconephrology Social media @isn_india @onconephsociety SoMe editor @NDTsocial @CKJsocial @ERAKidney

ID: 1200367137115652096

linkhttps://www.instagram.com/jazz_doc21?igsh=MXc4OTQ1aDRxdTR6&utm_source=qr calendar_today29-11-2019 10:53:37

3,3K Tweet

25,25K Followers

6,6K Following

Jasmine Sethi (@jasminenephro) 's Twitter Profile Photo

🆕CONFIDENCE trial 📌 Among persons with both CKD ➕ T2D👉therapy with finerenone plus empagliflozin led to a greater reduction in urinary ACR than either alone pubmed.ncbi.nlm.nih.gov/40470996/ #ERA25 Rajiv Agarwal MD, MS VA by Edgar V. Lerma 🇵🇭

🆕CONFIDENCE trial 

📌 Among persons with both CKD ➕ T2D👉therapy with finerenone plus empagliflozin led to a greater reduction in urinary ACR than either alone 

pubmed.ncbi.nlm.nih.gov/40470996/

#ERA25 <a href="/AgarwalRajivMD/">Rajiv Agarwal MD, MS</a> 

VA by <a href="/edgarvlermamd/">Edgar V. Lerma 🇵🇭</a>
Indian Society of Nephrology (@isn_india) 's Twitter Profile Photo

Case Presentations in Nephrology - An Indian Society of Nephrology Initiative Date : 12th June 2025 Thursday Time : 8:30 PM IST Onwards Topic: Case of Anasarca Moderator: Prof Vivekanand Jha, Chandigarh Vivekanand Jha | विवेकानन्द झा Presented by - Dr Jugal Mehta (Mumbai) Register at this link 👉

Case Presentations in Nephrology - An Indian Society of Nephrology Initiative 
Date : 12th June 2025 Thursday
Time : 8:30 PM IST Onwards
Topic: Case of Anasarca
Moderator: Prof Vivekanand Jha, Chandigarh <a href="/vjha126/">Vivekanand Jha | विवेकानन्द झा</a> 
Presented by - Dr Jugal Mehta (Mumbai)
Register at this link 👉